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Background: The objective of this study was to document our experience with supportive therapy without 
antivenom in snakebite management. 
Methods: In a prospective study undertaken at Gulu Regional Hospital, Northern Uganda from January to 
December 2002 the outcome of supportive therapy in management of 108 cases of snakebite was assessed. 
Results: The lower extremity was involved in 106 patients (98.1%) and the upper extremity in the remaining 
two cases. Sixty-two patients (57.4 %) did not get any First Aid prior to admission. All Patients received 
supportive therapy. None of the patients received snake antivenom since it was unavailable at the hospital. All 
the 108 patients (100 %) improved and were discharged. The duration of hospital stay was 2 to 17 days with 
a mean of 3.8 days. Conclusion: Supportive therapy is simple, safe and effective treatment for snakebite 
without serious systemic poisoning. 
Introduction 
Snakebite is a frightening experience for the patient 
and is a medical emergency'-5. Poisonous snakebite 
can result in sudden death. Death can also result from 
shock due to fright (fright deaths) even when the bites 
were by non-poisonous snakes. Urgent therapeutic 
measures are therefore very important in the 
management'-3. Poisonous snakes have a pair of fangs 
projecting from the maxillae through which venom is 
injected into the victim during the bite3-G. Snakes are - 
found throughout most parts of tropics and temperate 
zones5. Non-poisonous snakes have rows of teeth and 
these distinguishing features are important in the 
appropriate management of the victims ofsnakebites3. 
In United States, there are nearly 8000 poisonous 
snakebite cases per annum with 10-20  death^^.^. 
Australia, which is another snake-inhabited country, 
has an annual incidence of about 3000 cases with 1 
or 2 deaths2. The incidence of snakebite in Uganda is 
unknown. 
The mortality rate of untreated poisonous snakebites 
is as high as 40-50 %2. Worldwide there are about 
30000-40000 deaths from snakebites per annum5. 
Most deaths occur in children, the elderly, cases of 
delayed, inadequate or no treatment and religious sects 
who handle venomous snakes'-6. Non-poisonous 
snakebites may cause serious infection from bacteria 
such as clostridium and other anaerobes found in the 
snake's mouth. 
Most snakebites follow accidental stepping on the 
snake by unprotected, bare footed persons5. Snakebite 
poisoning results from effects of venom injection 
(envenomation) into the victim. Venom can also be 
absorbed from cuts or scratches5. Venom is a complex 
mixture of toxic and enzymatic proteins. Effects of 
these toxins include; haemotoxicity-damage to blood 
vessels resulting in spontaneous systemic bleeding 
(petechiae, ecchymosis, haematemesis, haematuria, 
muscle paralysis, myolysis, haemolysis, arrhythmias 
and heart failure, renal failure from shock or  
haemoglobinuria. However, in up to  30% of 
poisonous snakebites envenomation does not occur. 
This is because poisonous snakes are not always 
charged with ven~m~*~* ' .  
Manifestations of snakebite poisoning may be local 
and/or systemic'-'0. Local symptoms and signs include 
presence of fang marks, local bleeding, local swelling 
(oedema), bruising or discoloration. Systemic features 
include persistent or transient hypotension (shock) 
syncope (fainting), nausea, vomiting, diarrhoea, 
excessive salivation, paralysis, coagulopathy, and 
systemic haemorrhage. The symptoms are at their 
worst 12-24 hours2.3-s-6 following the bite and this 
allows for grading of snakebite severity to be done at 
the end ofthat period. Grading oflevels envenomation 
can also be done using ELIZAQo determine venom 
antieen levels in the ~atients '  serum. The level of " 
venomati ltes well v vith symptom severity 
and is a good guide to patient management with 
antivenom, as higher grades require more 
a n t i v e n ~ m ~ . ~ . ~ .  
Basic investigations'-' in snakebite include; hll blood 
counts,  blood grouping and cross-matching, 
prothrombin time, ECG, serum electrolytes, urea, 
creatinine and where available venom detection from 
the snakebite wounds, using venom detection kits2. 
The  management of snakebite though urgent is 
controversial1-'O in some aspects. T h e  outcome 
however depends on the type of the snake and the 
levels of enven~mation'-~. The mainstay of treatment 
for snakebite poisoning is antivenom'-lo. However, 
First Aid in the field or at home is important and 
should include procedures such as splinting the bitten 
limb, wound dressing with a firm bandage, reassurance 
and immediate transport to a medical facility where 
supportive therapy and antivenom are available. 
Procedures such as application of a loose tourniquet 
proximal to the bite, incision and suction of the fang 
marks and excision of the fang marks are controversial 
but may be helphl in skilled hands. Ifthe snake is killed 
it should be identified. Ifit is non-poisonous, reassuring - 
the patients is important. For less seriously ill victims, 
general supportive treatment is sufficient1-lo. The aims 
of this prospective study were to assess:the outcome of 
supportive therapy in absence ofantivenom in snakebite 
management at Gulu Regional Hospital. 
Patients and methods 
Between January and December 2002, there were 108 
patients with snakebites admitted at Gulu Regional 
Hospital in Northern Uganda. The diagnosis was 
based on the history and/or the presence of fang 
marks. The patients' ages, sex, place of bite, residential 
address, time interval between snakebite and 
admission to hospital, type of First Aid received, 
symptoms, local and systemic signs of snakebite 
envenomation, type of treatment given, comp1ira:ions 
and duration of hospital stay were recorded. 
Treatment included bed rest, l imb elevation, 
reassurance and sedation with diazepam or  
promethazine, wound dressing with iodine, antibiotic 
prophylaxis, tetanus toxoid, analgesics, steroid therapy, 
observation with or  without intravenous fluid 
administration. No antivenom was administered in 
all cases being unavailable in the hospital. Patients were 
discharged on recovery from local and systemic effects 
of snakebite. Data was analyzed to assess the outcome 
of supportive treatment. 
Results 
During the period under review, there were 1702 
surgical admissions of  which 108 (6.3%) had 
snakebites distributed throughout the year (Figure 1). 
The peak incidence was in the month of May. There 
were 47 males and 61 females (M: F= 1:1.3). The 
ages ranged from 1 year to 64 years with a mean of 
24.5 years (Table 1). Most of the patients did not 
receive any First Aid prior to admission. The lower 
limb was bitten in 106 (98.1%) and the upper limb 
in 2 (1.9%). None of the 108 victims had protective 
foot ware at the time of the bite. Table 2 summarizes 
the presenting clinical features. All patients had fang- 
marks. While on the ward, wounds were cleaned with 
iodine or hibitane (0.5 %). 
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Figure 1: Monthly distribution of snakebites b z  2002 
Table 1 : Age Distribution 
Table 2. Manifestations of Snakebite 
Age in years 








Table 3. Field First Aid Treatment. 



















































First Aid measure 
Tourniquet 












Table 4. Hospital Treatment - General Supportive Therapy 
1 3. 1 Reassurance 
1. 
2. 
1 4. 1 Sedation (Diazepam, Promethazine) 
Bed rest 
Wound dressing (iodine, hibitane) 
5. 
6 .  
7. 
8. 
Analgesics (ASA, Paracetamol, Ibuprofen, Indomethacin, Pethidine) 
Prophylactic antibiotics (PPF, Amoxycillin, Ampicillin, Gentamicin, Cloxacillin) 
Tetanus Toxoid 
Steroid (Hvdrocortisone, Dexamethasone) 
9. 
10. 
Table 4 shows the supportive treatment given to the 
snakebite patients. The patients were monitored for 
any  complications.  Two pat ients  had  w o u n d  
debridement following cellulitis that caused local 
tissue necrosis. All the 108 patients improved on 
treatment and were discharged. T h e  duration of 
hospital stay ranged 2 and 17 days with an average of 
3.8 days. 
Intravenous access (Fluids and Drugs) 




Snakebite was seen throughout the year but had a peak 
during the wet and dry seasons, which are the cropping 
and harvest seasons respectively, when the barefooted 
peasants ate busy in the snake - inhabited bushy fields 
in the rural areas6. All age groups were affected but 
the majority of the victims in our series were adults 
aged over 20 years. The  slightly higher incidence 
among females is presumably due to the additional 
risk from outdoor activities such as gardening6, 
collecting food or firewood from the fields or bushes5. 
Most of our patients had bites in the lower extremity 
which finding was in agreement with findings by other 
 researcher^'.^. Lack of protective foot-ware like leather 
boots while in a snake area is a predisposing factor to 
sr~akebite~.~.  
All t he  1 0 8  patients in this s tudy  had local 
Limb Elevation 
Observation 
manifestation of poisonous snakebite but few had mild 
lcatuirs of sys~cmic poisoning. Ir. is known that 
manifestations of snakebite depend on many factors 
but most importantly on the type of snake and the 
quantity of venom injected (level of envenomation or 
grade severity ~ f s n a k e b i t e ) ~ . ~ , ~ .  Snake type gives a clue 
to  the  venom-type a n d  the  nature  o f  clinical 
manifestation in the victim. If the offending snake 
was not killed searching for it could probably result 
in a second bite3v5. I t  is however probable that the 
quantities of injected venom (levels of envenomation) 
were low leading to less serious symptoms and signs. 
Future studies in this aspect of snakebites should be 
encouraged. 
The management ofvenomous snakebites is a medical 
emergency that requires immediate First Aid, general 
and specific measures'-3. The local traditional First Aid 
practices like strapping a coin or black stone against 
the snakebite wound, use of local topical medicaments 
are unconventional and unreliable and may result in 
complications. Although First Aid practices such as 
applying a loose tourniquet proximal to the bite, 
incision a n d  suct ion o f  the  wound ,  may be 
controversial1-', other practices such as immobilizing 
the bitten extremity, wound dressing after allowing 
local bleeding for 15-30 seconds are recommended 
as is the immediate transport of the victim to the 
nearest medical facility for definitive therapyG. 
Preventing exercise or  exertion after snakebite 
minimizes systemic absorption o f v e n ~ m ~ . ~ , ~  . Incision 
and suction of the bite wound for 30 minutes and 
within 30 minutes of the snakebite may remove up 
to 50% of the venom. A Loose tourniquet (not 
arterial) applied within 30 minutes proximal to the 
bite to  obstruct  venous and  lymphatic flow is 
recommended in some series but it should not be kept 
for more than 4 hours. It should be removed as soon 
as antivenom is administered. However, the tourniquet 
should be removed gradually to avoid spilling ofvenom 
into the circulation. 
General supportive therapy1-* has been effective in the 
management of snakebite patients with or without 
systemic poisoning; the former category of patients will 
in addition require antivenom treatment1-lo. In this 
study supportive treatment was simple and only a few 
patients with systemic symptoms had 1.V access for 
fluids and drugs for a day. It is possible in this study we 
did not get any patients with serious systemic poisoning. 
Presumably due to the snake type involved and 
perhaps small amount of venom injected. In practice, 
it is known that only 1 in 20 snakebite patients require 
active emergency management including antivenom 
therapyZ which is the mainstay of treatment for 
snakebite with systemic poisoning1-lo. Antivenom is 
available as monovalent (monospecific) and polyvalent 
preparations. It is prepared from horse serum and 
hypersensitivity, including anaphylaxis (incidence is 
under 1 %) can Antivenom should be 
administered either in the Emergency Room or 
Intensive Care Unit (ICU) where there are resuscitation 
faci l i t ie~~~~.~.  A test dose of 0.02 ml of antivenom diluted 
in 1:100 normal saline is given intradermally, with 0.25 
mg of adrenaline ready in a syringe in case of 
anaphylaxis2. 
Other series recommend premeditation2 for antivenom 
treatment as follows: non-sedating antihistamine e.g. 
promethazine 0.25 mg /kg, subcutaneous adrenaline 
0.25 mg and 1.V hydrocortisone 2 mg /kg. Antivenom 
is given by 1.V drip in 500 mls of normal saline or 5 % 
Dextrose s 1 0 w l ~ ~ ~ ~  in not less than 1 hour or by slow 
push 1.V injection not more than 2 ml / minute. The 
dose of antivenom is titrated against clinical response. 
Children get the same dose as adults. Initially 3-5 
ampoules of antivenom will be required, 6-8 ampoules 
may be required late$. Serum sickness occurs up to 14 
days after antivenom treatment and therefore steroid 
therapy (prednisolone Img/kg) and follow up are 
advised2. 
Conclusion 
Snakebites are a public health hazard in Gulu, Northern 
Uganda. Supportive therapy is simple, safe and effective 
treatment for snakebites without serious systemic 
poisoning. 
Recommendation 
Although general supportive therapy is effective in 
less serious snakebites, antivenom should be readily 
available all the time for administration in cases of 
systemic snakebite poisoning. 
- The public should be made aware of the burden of 
snakebites, their prevention and pre-hospital care. 
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